influvac tetra inj. susp. s.c./i.m. pre-filled syr.
viatris healthcare sa-nv - influenzavirus a-h3n2 surface antigen 15 µg/dose; influenzavirus b surface antigen 15 µg/dose; influenzavirus b surface antigen 15 µg/dose; influenzavirus a-h1n1 surface antigen 15 µg/dose - suspension for injection in pre-filled syringe - influenza virus, inactivated, tetravalent, haemagglutinine and neuraminidase units - influenza, inactivated, split virus or surface antigen
influvac
abbott laboratories sa (pty) ltd - influenza vaccine (surface antigen, inactivated) - injectable; injection - 15; 15; 15mcg/ml
influvac tetra vacuna anti influenza 0.5 ml jeringa
abbott biologicals b.v. - b/colorado/06/2017- like strain (b/maryland/15/2016, nymc bx-69a) (victoria lineage - b/colorado/06/2017- like strain (b/maryland/15/2016, nymc bx-69a) (victoria lineage.... 15 mcg
influvac vaccine solution
abbott biologicals, netherlands - a/victoria/2570/2019 (h1n1)pdm09- like virus,a/darwin/9/2021 (h3n2)-like virus,b/austria/1359417/2021 (b/victoria lineage)-like virus - solution - 15,15,15 µg,
influvac suspension for injection haemagglutinin of: • a/victoria/2570/2019 (h1n1) pdm09-like strain (a/victoria/2570/2019, ivr-215) 15 µg haemagglutinin • a/darwin/9/2021 (h3n2)-like strain (a/darwin/6/2021, ivr-227) 15 µg haemagglutinin • b/austria/1359417/2021-like strain (b/austr
abbott laboratories s.a (pty) ltd., south africa - vaccine - suspension for injection - haemagglutinin of: • a/victoria/2570/2019 (h1n1) pdm09-like strain (a/victoria/2570/2019, ivr-215) 15 µg haemagglutinin • a/darwin/9/2021 (h3n2)-like strain (a/darwin/6/2021, ivr-227) 15 µg haemagglutinin • b/austria/1359417/2021-like strain (b/austr
influvac subunit 2021 injection
abbott laboratories s.a. (pty) ltd - injection - see ingredients - each 0,5 ml syringe contains influenza virus a/california/7/2009(h1n1)v-l 15,0 ug influenza virus a/victoria/361/2011 (h3n2) 15,0 ug influenza virus b/wisconsin/1/2010 15,0 ug
influvac tetra injection
abbott laboratories s.a. (pty) ltd - injection - see ingredients - each 0,5 ml suspension contains influenza virus vaccine
influvac® tetra
influenza virus antigen, influenza virus antigen, influenza virus antigen, influenza virus antigen -
influvac® 2020/2021
influenza virus antigen, influenza virus antigen, influenza virus antigen -
influvac tetra suspension for injection (im/sc)
n/a; importer: abbott laboratories; distributor: abbott laboratories - quadrivalent seasonal influenza vaccine (surface antigen, inactivated) 2023 southern hemisphere strain - suspension for injection (im/sc) - each dose (0.5 ml) contains:* a/sydney/5/2021 (h1n1)pdm09-like strain. (a/sydney/5/2021, san-013) 15 ug ha** a/darwin/9/2021 (h3n2)-like strain (a/darwin/9/2021, san-010) 15 ug ha** b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) 15 ug ha** b/phuket/3073/2013-like strain (b/phuket/3073/2013, wild-type) 15 ug ha** *propagated in embryonated chicken eggs **haemagglutinin